Demographic and Clinical Characteristics of Chronic Myeloid Leukemia Patients: A Study on Confined Populations of Southern India

被引:1
|
作者
Gone, Manjula [1 ]
Sashidhar, R. B. [1 ]
Annamaneni, Sandhya [2 ]
Digumarti, Raghunadharao [3 ]
Satti, Vishnupriya [2 ]
机构
[1] Osmania Univ, Univ Coll Sci, Dept Biochem, Hyderabad, Telangana, India
[2] Osmania Univ, Univ Coll Sci, Dept Genet, Hyderabad 500007, Telangana, India
[3] Nizams Inst Med Sci, Dept Med Oncol, Hyderabad, Telangana, India
关键词
Chronic myeloid leukemia; clinical variable; epidemiology; imatinib mesylate; survival; SURVIVAL; RISK; CHLORPYRIFOS; GENDER; CML;
D O I
10.4103/ijmpo.ijmpo_141_17
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: Chronic myeloid leukemia (CML) is one of the most common hematological malignancies in all populations throughout the world. Even though the pathophysiology of CML was well explained in majority of the studies, the incidence of CML was shown to exhibit population diversity, and hence, the demographic factors underlying CML origin remain to be understood. Further, the introduction of tyrosine kinase inhibitors had revolutionized the treatment of CML over the years; however, there is a need for developing tailoring therapy to individual risk since the patient clinical heterogeneity poses a major problem during drug response. Therefore, the study of basic clinical picture may aid in planning treatment strategies for CML patients. Aim: The aim of this article is to study the epidemiological and clinical variables associated with the prognosis of CML. Subjects and Methods: We have considered the distribution of various demographic and clinical variables among 476 CML patients diagnosed at Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India. Statistical Analysis Used: All the analyses were performed through SPSS software (version 21.0). Correlation and Cox regression analyses were also performed. Results: Apart from the elevated male sex ratio in CML incidence, high frequency of males was observed to be nonresponders to imatinib mesylate (IM). IM response was shown to be dependent on phase of diagnosis, whereas overall survival of CML patients depends on the age at onset and response to IM. Conclusions: The study of epidemiology and clinical picture of CIVIL patients may help in planning better treatment strategies at diagnosis to achieve long-term progression-free survival.
引用
收藏
页码:S70 / S76
页数:7
相关论文
共 50 条
  • [1] Demographic, clinical, and hematologic characteristics of patients with chronic myeloid leukemia in Upper Egypt: association with treatment responses
    Khaled, Safaa A. A.
    El Aziz, Nashwa M. A. Abd
    [J]. EGYPTIAN JOURNAL OF HAEMATOLOGY, 2015, 40 (04): : 195 - 200
  • [2] CHROMOSOMAL CHARACTERISTICS OF CHRONIC AND BLASTIC PHASE OF CHRONIC MYELOID-LEUKEMIA - A STUDY OF 100 PATIENTS IN INDIA
    KADAM, PR
    NANJANGUD, GJ
    ADVANI, SH
    NAIR, C
    BANAVALI, S
    GOPAL, R
    SAIKIA, T
    [J]. CANCER GENETICS AND CYTOGENETICS, 1991, 51 (02) : 167 - 181
  • [3] Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia
    Belgaumi, Asim F.
    Al-Shehri, Ali
    Ayas, Mouhab
    Al-Mahr, Mohammed
    Al-Seraihy, Amel
    Al-Ahmari, Ali
    El-Solh, Hassan
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1211 - 1215
  • [4] Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study
    Korkmaz, Serdal
    Dal, Mehmet Sinan
    Berber, Ilhami
    Sahin, Deniz Goren
    Dogu, Mehmet Hilmi
    Ayyildiz, Orhan
    Nizam, Ilknur
    Albayrak, Murat
    Esen, Ramazan
    Namdaroglu, Sinem
    Sencan, Mehmet
    Akay, Olga Meltem
    Hacioglu, Sibel
    Yildirim, Rahsan
    Eser, Ali
    Tombak, Anil
    Pala, Cigdem
    Ilhan, Osman
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2015, 15 (06) : 729 - 735
  • [5] Demographic factors related to young age at diagnosis of chronic myeloid leukemia in India
    Levine, Paul H.
    Ajmera, Kunal
    O'Neill, Brenna
    Venkatesh, Viji
    Garcia-Gonzalez, Pat
    Hoffman, Heather J.
    [J]. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2016, 4 (04): : 188 - 192
  • [6] Chronic myeloid leukemia in India
    Goldman, John M.
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2013, 34 (03) : 147 - 148
  • [7] The clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study.
    Korkmaz, Serdal
    Dal, Mehmet Sinan
    Berber, Ilhami
    Sahin, Deniz Goren
    Dogu, Mehmet Hilmi
    Ayyildiz, Orhan
    Nizam, Ilknur
    Albayrak, Murat
    Esen, Ramazan
    Namdaroglu, Sinem
    Sencan, Mehmet
    Akay, Olga Meltem
    Hacioglu, Sibel Kabukcu
    Yildirim, Rahsan
    Eser, Ali
    Tombak, Anil
    Pala, Cigdem
    Ilhan, Osman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] SREALCLL STUDY: DEMOGRAPHIC CHARACTERISTICS AND TREATMENT REGIMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN CLINICAL PRACTICE IN SPAIN
    Pueyo Javier, Loscertales
    Costa Pau, Abrisqueta
    Jose Antonio, Garcia-Marco
    Antonio Manuel, Gutierrez Garcia
    Jose Angel, Hernandez Rivas
    Lapiedra Rafael, Andreu
    Alba, Mora
    Antonia, Cebollero Ma
    Mellen Angel, Callejo
    Carlota, Moya
    Carolina, Leiva
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 225 - 225
  • [9] Characteristics and survival of patients with atypical chronic myeloid leukemia
    Kong, Jee Hyun
    Nam, Hohyung
    Go, Tae-Hwa
    Hyun, Shin Young
    Shim, Kwang Yong
    [J]. BLOOD RESEARCH, 2019, 54 (03) : 233 - 236
  • [10] To study the demographic and clinico-haematological findings of chronic myeloid leukemia
    Qadir, Sidra
    Ujjan, Ikram Din
    Memon, Faheem
    Naz, Arshi
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2017, 22